Clinical and pathological analyses showed that high Notch3 levels (strong staining) were not significantly associated with tumor size and stage (Table 1), but the Kaplan-Meier analysis indicated that patients with high Notch3 levels had significantly shorter overall survival than those with low levels (Figure 2B, P < 0.001). Here, NOTCH3 is linked to neoplasm.